Androgen-Deprivation Therapeutic Drugs + MitapivatContraindicated
PYRUKYND may affect CYP2B6 substrates with narrow therapeutic index. Avoid concomitant use.
Source: NLP:mitapivat
Androgen-Deprivation Therapeutic Drugs Interactions
2 interactions on record
Androgen-deprivation therapy may interfere with 11C-choline PET imaging performance. Impact depends on hormonal responsiveness; imaging may be unproductive in hormone-responsive cancer patients but potentially useful in hormone-resistant cases.
Source: NLP:choline c-11